152 related articles for article (PubMed ID: 25328285)
21. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
LeBrasseur NK; Kelly M; Tsao TS; Farmer SR; Saha AK; Ruderman NB; Tomas E
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E175-81. PubMed ID: 16464908
[TBL] [Abstract][Full Text] [Related]
22. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators.
Pasceri V; Wu HD; Willerson JT; Yeh ET
Circulation; 2000 Jan; 101(3):235-8. PubMed ID: 10645917
[TBL] [Abstract][Full Text] [Related]
23. Effect of peroxisome proliferator-activated receptor gamma on thromboxane A(2) and prostaglandin E(2) production in macrophage cell lines.
Yamazaki T; Yokoo T; Tomioka Y; Suzuki H; Hishinuma T; Mizugaki M
Prostaglandins Leukot Essent Fatty Acids; 2002 Oct; 67(4):245-51. PubMed ID: 12401439
[TBL] [Abstract][Full Text] [Related]
24. The effects of troglitazone on AMPK in HepG2 cells.
Allen KM; Coughlan KA; Mahmood FN; Valentine RJ; Ruderman NB; Saha AK
Arch Biochem Biophys; 2017 Jun; 623-624():49-57. PubMed ID: 28526426
[TBL] [Abstract][Full Text] [Related]
25. Intensive Statin Therapy Compromises the Adiponectin-AdipoR Pathway in the Human Monocyte-Macrophage Lineage.
Gasbarrino K; Hafiane A; Zheng H; Daskalopoulou SS
Stroke; 2019 Dec; 50(12):3609-3617. PubMed ID: 31648632
[TBL] [Abstract][Full Text] [Related]
26. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
27. Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK.
Deng R; Nie A; Jian F; Liu Y; Tang H; Zhang J; Zhang Y; Shao L; Li F; Zhou L; Wang X; Ning G
Biochim Biophys Acta; 2014 Jan; 1840(1):577-85. PubMed ID: 24144566
[TBL] [Abstract][Full Text] [Related]
28. Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone.
Sell H; Dietze-Schroeder D; Eckardt K; Eckel J
Biochem Biophys Res Commun; 2006 May; 343(3):700-6. PubMed ID: 16563350
[TBL] [Abstract][Full Text] [Related]
29. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages.
Ringseis R; Schulz N; Saal D; Eder K
J Nutr Biochem; 2008 Sep; 19(9):594-603. PubMed ID: 18155510
[TBL] [Abstract][Full Text] [Related]
30. Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages.
Minge CE; Ryan NK; Van Der Hoek KH; Robker RL; Norman RJ
Biol Reprod; 2006 Jan; 74(1):153-60. PubMed ID: 16192401
[TBL] [Abstract][Full Text] [Related]
31. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines.
Liu X; Yu H; Yang L; Li C; Li L
Eur J Cell Biol; 2012 Aug; 91(8):654-61. PubMed ID: 22560326
[TBL] [Abstract][Full Text] [Related]
32. [AMP-activated protein kinase-alpha is involved in the autophagy and apoptosis caused by troglitazone].
Jin X; Yuan D; Chen X; Jiang X
Wei Sheng Wu Xue Bao; 2012 Jul; 52(7):840-9. PubMed ID: 23115968
[TBL] [Abstract][Full Text] [Related]
33. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
Pandhare J; Cooper SK; Phang JM
J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin/adipoR1/AMPK pathway.
Quaresma PG; Reencober N; Zanotto TM; Santos AC; Weissmann L; de Matos AH; Lopes-Cendes I; Folli F; Saad MJ; Prada PO
Int J Obes (Lond); 2016 Jan; 40(1):138-46. PubMed ID: 26228462
[TBL] [Abstract][Full Text] [Related]
35. Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells.
Konrad D; Rudich A; Bilan PJ; Patel N; Richardson C; Witters LA; Klip A
Diabetologia; 2005 May; 48(5):954-66. PubMed ID: 15834551
[TBL] [Abstract][Full Text] [Related]
36. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
Naitoh T; Kitahara M; Tsuruzoe N
Cell Biol Toxicol; 2000; 16(2):131-5. PubMed ID: 10917568
[TBL] [Abstract][Full Text] [Related]
37. Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte/macrophage cell.
McClelland S; Cox C; O'Connor R; de Gaetano M; McCarthy C; Cryan L; Fitzgerald D; Belton O
Atherosclerosis; 2010 Jul; 211(1):96-102. PubMed ID: 20223456
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes.
Sigrist S; Bedoucha M; Boelsterli UA
Biochem Pharmacol; 2000 Jul; 60(1):67-75. PubMed ID: 10807946
[TBL] [Abstract][Full Text] [Related]
39. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
[TBL] [Abstract][Full Text] [Related]
40. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]